Home >> Marketplace Directory >> RBCX cleared on Spectra Optia system, 4/14

RBCX cleared on Spectra Optia system, 4/14

image_pdfCreate PDF

April 2014—Terumo BCT received FDA 510(k) clearance for red blood cell exchange on the Spectra Optia Apheresis System. This option gives clinicians the flexibility to perform exchange, depletion, and depletion/exchange procedures on the Spectra Optia system and to tailor each procedure for the transfusion management of sickle cell disease in adults and children.

Terumo BCT, 303-205-2546

CAP TODAY
X